Hillsdale Investment Management Inc. acquired a new position in Cognex Corporation (NASDAQ:CGNX – Free Report) during the first quarter, Holdings Channel reports. The firm acquired 65,200 shares of the scientific and technical instruments company’s stock, valued at approximately $3,194,000.
Several other institutional investors have also modified their holdings of CGNX. Royal Bank of Canada raised its position in Cognex by 13.2% in the first quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock worth $5,976,000 after acquiring an additional 23,326 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Cognex during the 1st quarter valued at about $291,000. Intech Investment Management LLC boosted its position in shares of Cognex by 24.1% during the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company’s stock valued at $1,415,000 after purchasing an additional 9,223 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of Cognex by 7.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock worth $419,000 after purchasing an additional 920 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.
Insider Transactions at Cognex
In related news, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the completion of the sale, the insider directly owned 11,263 shares in the company, valued at approximately $755,184.15. This trade represents a 85.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the transaction, the vice president directly owned 5,258 shares in the company, valued at $344,714.48. The trade was a 88.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,847 shares of company stock valued at $14,975,098 over the last three months. 1.70% of the stock is owned by corporate insiders.
Cognex Trading Down 2.8%
Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same period in the prior year, the business earned $0.14 EPS. The business’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, sell-side analysts predict that Cognex Corporation will post 1.48 EPS for the current year.
Cognex Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were issued a $0.085 dividend. The ex-dividend date was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s dividend payout ratio is currently 40.48%.
Wall Street Analysts Forecast Growth
CGNX has been the subject of several recent research reports. Citigroup reissued a “neutral” rating and set a $72.00 target price (up from $68.00) on shares of Cognex in a research note on Monday. Stephens lifted their price target on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Truist Financial upped their price target on Cognex from $61.00 to $71.00 and gave the company a “hold” rating in a report on Thursday, July 2nd. Sanford C. Bernstein reiterated an “outperform” rating and set a $75.00 price objective on shares of Cognex in a research report on Thursday, May 7th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cognex in a research note on Friday, May 15th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $72.31.
Cognex Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
See Also
- Five stocks we like better than Cognex
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
